Literature DB >> 17233799

Fluoroquinolone use is the predominant risk factor for the development of a new strain of clostridium difficile-associated disease.

Nilay S Patel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17233799     DOI： 10.1111/j.1464-410X.2006.06741.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  2 in total

1.  Treatment duration of febrile urinary tract infections.

Authors:  Willize E van der Starre; Jaap T van Dissel; Cees van Nieuwkoop
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

2.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

Authors:  Richard A Stabler; Miao He; Lisa Dawson; Melissa Martin; Esmeralda Valiente; Craig Corton; Trevor D Lawley; Mohammed Sebaihia; Michael A Quail; Graham Rose; Dale N Gerding; Maryse Gibert; Michel R Popoff; Julian Parkhill; Gordon Dougan; Brendan W Wren
Journal:  Genome Biol       Date:  2009-09-25       Impact factor: 13.583
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.